During the past decade, Gastroenterologie und Hepatologie am Johannisplatz conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastroenterologie und Hepatologie am Johannisplatz" are "Crohn's Disease" (1 trials) and "Male Subjects With Chronic Constipation" (1 trials). Many other conditions were trialed in "Gastroenterologie und Hepatologie am Johannisplatz" in a lesser frequency.

Most popular intervention types in "Gastroenterologie und Hepatologie am Johannisplatz" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials), "Guselkumab Dose 2" (1 trials) and "Guselkumab Dose 3" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterologie und Hepatologie am Johannisplatz" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gastroenterologie und Hepatologie am Johannisplatz". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gastroenterologie und Hepatologie am Johannisplatz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterologie und Hepatologie am Johannisplatz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".